Lipocine Inc.
NASDAQ: LPCN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mahesh V. Patel
- Employees
- 16
- Headquarters
- Salt Lake City, United States
- IPO year
- 2013
- Market cap
- $14.3M
- Website
- https://www.lipocine.com
Loading LPCN…
Loading profile data…Frequently asked questions about LPCN
What does Lipocine Inc. (LPCN) do?
Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typical...
Where does LPCN trade?
Lipocine Inc. (LPCN) trades on the NASDAQ Capital Market.
What sector is LPCN in?
Lipocine Inc. (LPCN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lipocine Inc.?
Mahesh V. Patel is the chief executive officer of Lipocine Inc. (LPCN).
Where is Lipocine Inc. headquartered?
Lipocine Inc. is headquartered in United States.
Does LPCN pay a dividend?
Lipocine Inc. (LPCN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LPCN go public?
Lipocine Inc. (LPCN) completed its initial public offering in 2013.